121 related articles for article (PubMed ID: 23590230)
1. 12-OH-nevirapine sulfate, formed in the skin, is responsible for nevirapine-induced skin rash.
Sharma AM; Novalen M; Tanino T; Uetrecht JP
Chem Res Toxicol; 2013 May; 26(5):817-27. PubMed ID: 23590230
[TBL] [Abstract][Full Text] [Related]
2. Nevirapine bioactivation and covalent binding in the skin.
Sharma AM; Klarskov K; Uetrecht J
Chem Res Toxicol; 2013 Mar; 26(3):410-21. PubMed ID: 23387501
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of the metabolic pathway responsible for nevirapine-induced skin rash.
Chen J; Mannargudi BM; Xu L; Uetrecht J
Chem Res Toxicol; 2008 Sep; 21(9):1862-70. PubMed ID: 18729332
[TBL] [Abstract][Full Text] [Related]
4. Identification of danger signals in nevirapine-induced skin rash.
Zhang X; Sharma AM; Uetrecht J
Chem Res Toxicol; 2013 Sep; 26(9):1378-83. PubMed ID: 23947594
[TBL] [Abstract][Full Text] [Related]
5. Sulfation of 12-hydroxy-nevirapine by human SULTs and the effects of genetic polymorphisms of SULT1A1 and SULT2A1.
Kurogi K; Cao Y; Segawa K; Sakakibara Y; Suiko M; Uetrecht J; Liu MC
Biochem Pharmacol; 2022 Oct; 204():115243. PubMed ID: 36084709
[TBL] [Abstract][Full Text] [Related]
6. A study of the specificity of lymphocytes in nevirapine-induced skin rash.
Chen X; Tharmanathan T; Mannargudi B; Gou H; Uetrecht JP
J Pharmacol Exp Ther; 2009 Dec; 331(3):836-41. PubMed ID: 19734442
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a potential animal model of an idiosyncratic drug reaction: nevirapine-induced skin rash in the rat.
Shenton JM; Teranishi M; Abu-Asab MS; Yager JA; Uetrecht JP
Chem Res Toxicol; 2003 Sep; 16(9):1078-89. PubMed ID: 12971795
[TBL] [Abstract][Full Text] [Related]
8. Bioactivation of nevirapine to a reactive quinone methide: implications for liver injury.
Sharma AM; Li Y; Novalen M; Hayes MA; Uetrecht J
Chem Res Toxicol; 2012 Aug; 25(8):1708-19. PubMed ID: 22793666
[TBL] [Abstract][Full Text] [Related]
9. HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients.
Chantarangsu S; Mushiroda T; Mahasirimongkol S; Kiertiburanakul S; Sungkanuparph S; Manosuthi W; Tantisiriwat W; Charoenyingwattana A; Sura T; Chantratita W; Nakamura Y
Pharmacogenet Genomics; 2009 Feb; 19(2):139-46. PubMed ID: 19104471
[TBL] [Abstract][Full Text] [Related]
10. Nevirapine hypersensitivity.
Popovic M; Shenton JM; Chen J; Baban A; Tharmanathan T; Mannargudi B; Abdulla D; Uetrecht JP
Handb Exp Pharmacol; 2010; (196):437-51. PubMed ID: 20020271
[TBL] [Abstract][Full Text] [Related]
11. Investigating the Mechanism of Trimethoprim-Induced Skin Rash and Liver Injury.
Cao Y; Bairam A; Jee A; Liu M; Uetrecht J
Toxicol Sci; 2021 Feb; 180(1):17-25. PubMed ID: 33394045
[TBL] [Abstract][Full Text] [Related]
12. Potential Involvement of Sulfotransferase in the Mechanism of Lamotrigine-induced Skin Rash.
Cao Y; Bairam A; Liu MC; Uetrecht J
Chem Res Toxicol; 2023 Nov; 36(11):1711-1716. PubMed ID: 37922508
[TBL] [Abstract][Full Text] [Related]
13. Study of the sequence of events involved in nevirapine-induced skin rash in Brown Norway rats.
Popovic M; Caswell JL; Mannargudi B; Shenton JM; Uetrecht JP
Chem Res Toxicol; 2006 Sep; 19(9):1205-14. PubMed ID: 16978025
[TBL] [Abstract][Full Text] [Related]
14. Human sulfotransferase 1A1-dependent mutagenicity of 12-hydroxy-nevirapine: the missing link?
Kranendonk M; Alves M; Antunes P; Rueff J
Chem Res Toxicol; 2014 Nov; 27(11):1967-71. PubMed ID: 25275777
[TBL] [Abstract][Full Text] [Related]
15. Amino acid adduct formation by the nevirapine metabolite, 12-hydroxynevirapine--a possible factor in nevirapine toxicity.
Antunes AM; Godinho AL; Martins IL; Justino GC; Beland FA; Marques MM
Chem Res Toxicol; 2010 May; 23(5):888-99. PubMed ID: 20392079
[TBL] [Abstract][Full Text] [Related]
16. Evidence of an immune-mediated mechanism for an idiosyncratic nevirapine-induced reaction in the female Brown Norway rat.
Shenton JM; Popovic M; Chen J; Masson MJ; Uetrecht JP
Chem Res Toxicol; 2005 Dec; 18(12):1799-813. PubMed ID: 16359170
[TBL] [Abstract][Full Text] [Related]
17. Quantifying the metabolic activation of nevirapine in patients by integrated applications of NMR and mass spectrometries.
Srivastava A; Lian LY; Maggs JL; Chaponda M; Pirmohamed M; Williams DP; Park BK
Drug Metab Dispos; 2010 Jan; 38(1):122-32. PubMed ID: 19797610
[TBL] [Abstract][Full Text] [Related]
18. Nevirapine-induced liver lipid-SER inclusions and other ultrastructural aberrations.
Sastry J; Mohammed H; Campos MM; Uetrecht J; Abu-Asab M
Ultrastruct Pathol; 2018; 42(2):108-115. PubMed ID: 29424579
[TBL] [Abstract][Full Text] [Related]
19. Sex differences in hepatic and intestinal contributions to nevirapine biotransformation in rats.
Pinheiro PF; Marinho AT; Antunes AM; Marques MM; Pereira SA; Miranda JP
Chem Biol Interact; 2015 May; 233():115-21. PubMed ID: 25818046
[TBL] [Abstract][Full Text] [Related]
20. Case-control exploration of relationships between early rash or liver toxicity and plasma concentrations of nevirapine and primary metabolites.
Hall DB; Macgregor TR
HIV Clin Trials; 2007; 8(6):391-9. PubMed ID: 18042504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
